Lurasidon Hydrochloride Intermediate CAS 14805-29-9 Purity ≥99.0% (HPLC) Factory High Purity
Ubonelelo loMvelisi iLurasidone Hydrochloride eNxulumeneyo neMiphakathi:
(1R,2R)-1,2-Cyclohexanedimethanol CAS 65376-05-8
(3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione CAS 14805-29-9
Lurasidone Hydrochloride CAS 367514-88-3 API
Igama leMchiza | (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
Izithethantonye | exo-2,3-Norbornanedicarboximide;I-Lurasidon Hydrochloride ePhakathi |
Inombolo yeCAS | 14805-29-9 |
Inombolo yeCAT | RF-PI264 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C9H11NO2 |
Ubunzima beMolekyuli | 165.19 |
Ukuxinana | 1.285 |
Imeko yokuthumela ngenqanawa | Ithunyelwe Ngaphantsi Kweqondo Lobushushu njengeMichiza engeyongozi |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya Phantse uMhlophe |
Indawo yokunyibilika | 150.0 ~ 154.0℃ |
Yahlula | H-NMR |
Compound eNxulumeneyo | ≤0.50% |
Endo Isomer | ≤0.15% |
Ukungcola A | ≤0.10% (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H) -dione |
Max.Ukungacoceki Okukodwa | ≤0.30% |
Ukungcola ngokupheleleyo | ≤1.0% |
Umxholo wamanzi | ≤1.0% |
Iintsimbi ezinzima | ≤20ppm |
Ubunyulu / Indlela yokuHlalutya | ≥99.0% (HPLC) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | I-Lurasidon Hydrochloride (CAS 367514-88-3) Phakathi |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, Igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione (CAS 14805) -29-9) ngomgangatho ophezulu, imveliso yorhwebo.Yonayinto ephakathi ngokuqhelekileyo kwi-synthesis yeLurasidon Hydrochloride (CAS 367514-88-3) kunyango lwe-Schizophrenia.
I-Lurasidone yavunywa yi-FDA kwi-2010 ye-schizophrenia kunye ne-2013 ngenxa yeziganeko ezixinzelelekileyo ezinxulumene ne-bipolar disorder.I-Lurasidone yinto elawulwa ngomlomo ephuma kwiklasi ye-atypical antipsychotic drug (AAPD).Ifumene imvume ye-EMA kwi-2014 ye-schizophrenia.I-Lurasidone iye yaqaliswa kwinani lamazwe angaphandle kwe-US kunye ne-EU, kuquka iCanada, apho ivunyiwe kuzo zombini izibonakaliso.Iveliswa ngenkqubo yeekhemikhali ezinamanyathelo amaninzi.